Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5290980
Max Phase: Preclinical
Molecular Formula: C25H23N5S
Molecular Weight: 425.56
Associated Items:
ID: ALA5290980
Max Phase: Preclinical
Molecular Formula: C25H23N5S
Molecular Weight: 425.56
Associated Items:
Canonical SMILES: Cc1cccc(C)c1-n1c(SCCc2c[nH]c3ccccc23)nnc1-c1ccncc1
Standard InChI: InChI=1S/C25H23N5S/c1-17-6-5-7-18(2)23(17)30-24(19-10-13-26-14-11-19)28-29-25(30)31-15-12-20-16-27-22-9-4-3-8-21(20)22/h3-11,13-14,16,27H,12,15H2,1-2H3
Standard InChI Key: OKMSSUYJEHKPFB-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 425.56 | Molecular Weight (Monoisotopic): 425.1674 | AlogP: 5.76 | #Rotatable Bonds: 6 |
Polar Surface Area: 59.39 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: 3.71 | CX LogP: 5.93 | CX LogD: 5.93 |
Aromatic Rings: 5 | Heavy Atoms: 31 | QED Weighted: 0.35 | Np Likeness Score: -1.46 |
1. Yakkala PA, Panda SR, Naidu VGM, Shafi S, Kamal A.. (2023) Pyridine-Based 1,2,4-Triazolo-Tethered Indole Conjugates Potentially Affecting TNKS and PI3K in Colorectal Cancer., 14 (3): [PMID:36923920] [10.1021/acsmedchemlett.2c00475] |
Source(1):